Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis.

Unlabelled: No therapies have been proven to increase survival after a hepatic encephalopathy (HE) episode. We hypothesize that two doses of albumin could improve 90-day survival rates after a HE episode.

Methods: (1) A randomized double-blind, placebo-controlled trial (BETA) was conducted in 12 hospitals.

[Rapid progression of hepatocellular carcinoma after surgery: apropos of a case and review of the literature].

We report the case of a young man with chronic hepatitis B infection of probable perinatal acquisition who was diagnosed with hepatocellular carcinoma at a very early stage (BCLC 0) with a highly favorable prognosis. However, the tumor progressed rapidly and the patient died within months. Currently, there are few data that could help to identify cases likely to show rapid progression and which could prompt initiation of aggressive therapies that might prevent or control such progression.

[Continuing care unit and day hospital as an alternative to conventional hospitalization: 10 years' experience in a district hospital].

Unlabelled: The continuing care unit and day hospital allows ambulatory care of patients with digestive diseases.

Aim: Reducing hospital admissions and the number of patients with digestive diseases that attend the emergency department.

Material And Methods: Two types of care are provided: a) continuing care; patients are urgently visited when they show acute decompensation of their digestive disease, and b) scheduled care: procedures that, due to their complexity, require nursing care but not necessarily hospital admission.